| Literature DB >> 28945761 |
R Angela Sarabdjitsingh1, Manila Loi1, Marian Joëls1,2, Rick M Dijkhuizen3, Annette van der Toorn3.
Abstract
Adverse experiences early in life impair cognitive function both in rodents and humans. In humans this increases the vulnerability to develop mental illnesses while in the rodent brain early life stress (ELS) abnormalities are associated with changes in synaptic plasticity, excitability and microstructure. Detailed information on the effects of ELS on rodent brain structural integrity at large and connectivity within the brain is currently lacking; this information is highly relevant for understanding the mechanism by which early life stress predisposes to mental illnesses. Here, we exposed rats to 24 hours of maternal deprivation (MD) at postnatal day 3, a paradigm known to increase corticosterone levels and thereby activate glucocorticoid receptors in the brain. Using structural magnetic resonance imaging we examined: i) volumetric changes and white/grey matter properties of the whole cerebrum and of specific brain areas; and ii) whether potential alterations could be normalized by blocking glucocorticoid receptors with mifepristone during the critical developmental window of early adolescence, i.e. between postnatal days 26 and 28. The results show that MD caused a volumetric reduction of the prefrontal cortex, particularly the ventromedial part, and the orbitofrontal cortex. Within the whole cerebrum, white (relative to grey) matter volume was decreased and region-specifically in prefrontal cortex and dorsomedial striatum following MD. A trend was found for the hippocampus. Grey matter fractions were not affected. Treatment with mifepristone did not normalize these changes. This study indicates that early life stress in rodents has long lasting consequences for the volume and structural integrity of the brain. However, changes were relatively modest and-unlike behavior- not mitigated by blockade of glucocorticoid receptors during a critical developmental period.Entities:
Mesh:
Year: 2017 PMID: 28945761 PMCID: PMC5612645 DOI: 10.1371/journal.pone.0185061
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Representative MR images of the rat brain.
A) High-resolution post-mortem anatomical images (100 x 100 x 100 μm3) of the rat brain template from all experimental animals (n = 40). Individual scans were registered to this template to perform voxel-wise comparisons on brain volume. B) Diffusion tensor imaging-based FA maps (150 x 150 x 150 μm3) of the rat brain template. The FA maps were used to analyze structural integrity properties of the white matter. C) ROIs, for example OFC (green), mPFC (purple), corpus callosum (red), dorsomedial striatum (blue) and hippocampus (yellow), depicted on the average rat brain template.
Volumes of the different ROIs based on high-resolution anatomical MRI.
N = 10 rats per group. Data represents mean ± SEM in μl and was analyzed using 2-way ANOVA with MD and mifepristone treatment as main factors. Statistical significance based on p-values for the main effect is presented in the last three columns: * p < 0.05, ** p < 0.01, ns = not significant.
| Vehicle | Mifepristone | MD | Treatment | Interaction | |||
|---|---|---|---|---|---|---|---|
| 1550.5 ± 10.0 | 1546.6 ± 11.9 | 1573.8 ± 16.1 | 1548.9 ± 15.7 | ns | ns | ns | |
| 30.4 ± 2.2 | 31.3 ± 2.4 | 31.0 ± 2.2 | 30.5 ± 3.0 | ns | ns | ns | |
| 40.1 ± 1.8 | 38.6 ± 0.7 | 39.6 ± 1.1 | 38.9 ± 1.3 | ns | ns | ns | |
| 91.0 ± 1.1 | 91.4 ± 0.7 | 91.3 ± 1.2 | 90.6 ± 1.4 | ns | ns | ns | |
| 29.2 ± 0.3 | 29.1 ± 0.3 | 29.4 ± 0.3 | 29.6 ± 0.5 | ns | ns | ns | |
| 16.8 ± 0.2 | 17.0 ± 0.3 | 17.6 ± 0.5 | 16.6 ± 0.3 | ns | ns | ns | |
| 101.7 ± 0.4 | 99.6 ± 0.3 | 101.4 ± 1.0 | 98.9 ± 1.1 | ** | ns | ns | |
| 22.9 ± 0.2 | 22.1 ± 0.1 | 22.4 ± 0.3 | 22.2 ± 0.2 | * | ns | ns | |
| 14.4 ± 0.3 | 13.6 ± 0.2 | 14.1 ± 0.2 | 13.1 ± 0.3 | ** | ns | ns | |
| 48.9 ± 0.3 | 48.5 ± 0.5 | 49.2 ± 0.7 | 48.9 ± 0.4 | ns | ns | ns | |
Relative volumes of white matter content to whole cerebrum in the different ROIs (n = 10 per group) calculated from the DTI scan.
Data represents percentage of total ROI volume in % (mean ± SEM). Data was analyzed using 2-way ANOVA with MD and mifepristone treatment as main factors. Statistical significance based on p-values for the main effects is presented in the last three columns: * p < 0.05, ** p < 0.01, ns = not significant.
| White matter | Vehicle | Mifepristone | MD | Treatment | Interaction | ||
|---|---|---|---|---|---|---|---|
| 13.3 ± 0.41 | 12.3 ± 0.22 | 12.5 ± 0.50 | 11.3 ± 0.60 | * | ns | ns | |
| 78.3 ± 1.39 | 77.5 ± 0.60 | 76.9 ±1.06 | 76.4 ± 1.34 | ns | ns | ns | |
| 11.0 ± 0.18 | 10.6 ± 0.32 | 10.2 ± 0.30 | 9.58 ± 0.38 | p = 0.06 | * | ns | |
| 3.92 ± 0.82 | 2.99 ± 0.36 | 3.09 ± 0.44 | 2.26 ± 0.51 | ns | ns | ns | |
| 2.40 ± 0.23 | 1.71 ± 0.13 | 2.14 ± 0.24 | 1.47 ± 0.22 | ** | ns | ns | |
| 1.23 ± 0.16 | 0.77 ± 0.14 | 0.78 ± 0.14 | 0.49 ± 0.14 | * | * | ns | |
| 2.80 ± 0.29 | 2.10 ± 0.31 | 2.32 ± 0.38 | 1.28 ± 0.31 | * | ns | ns | |
| 1.57 ± 0.24 | 1.11 ± 0.18 | 0.89 ± 0.15 | 0.81 ± 0.20 | ns | * | ns | |
| 2.08 ± 0.27 | 1.37 ± 0.18 | 1.34 ± 0.36 | 0.98 ± 0.27 | ns | ns | ns | |
Relative volumes of grey matter content to whole cerebrum in the different ROIs (n = 10 per group) calculated from the DTI scan.
Data represents percentage of total ROI volume in % (mean ± SEM). Data was analyzed using 2-way ANOVA with MD and mifepristone treatment as main factors. Statistical significance based on p-values for the main effects are described in the last three columns: * p < 0.05, ** p < 0.01, ns = not significant.
| Grey matter | Vehicle | Mifepristone | MD | Treatment | Interaction | ||
|---|---|---|---|---|---|---|---|
| 86.8 ± 0.73 | 87.0 ± 0.25 | 86.9 ± 0.50 | 87.6 ± 0.64 | ns | ns | ns | |
| 21.6 ± 1.39 | 22.5 ± 0.59 | 23.1 ± 1.07 | 23.6 ± 1.34 | ns | ns | ns | |
| 90.3 ± 0.98 | 89.3 ± 0.32 | 90.1 ± 0.44 | 91.2 ± 0.86 | ns | ns | ns | |
| 97.0 ± 0.58 | 97.0 ± 0.36 | 97.1 ± 0.46 | 97.7 ± 0.51 | ns | ns | ns | |
| 97.8 ± 0.27 | 98.2 ± 0.13 | 97.9 ± 0.23 | 98.0 ± 0.35 | ns | ns | ns | |
| 98.8 ± 0.16 | 99.0 ± 0.18 | 99.2 ± 0.15 | 99.3 ± 0.17 | ns | ns | ns | |
| 97.4 ± 0.35 | 97.8 ± 0.34 | 97.6 ± 0.39 | 98.4 ± 0.38 | ns | ns | ns | |
| 98.2 ± 0.25 | 98.4 ± 0.25 | 98.9 ± 0.16 | 99.0 ± 0.20 | ns | ** | ns | |
| 97.9 ± 0.35 | 98.2 ± 0.25 | 98.5 ± 0.36 | 98.4 ± 0.38 | ns | ns | ns | |
Mean diffusivity (10−3 mm2/s) and FA per ROI calculated from the DTI scan.
Data is expressed as mean ± SEM (n = 10 per group) and was analyzed using 2-way ANOVA with MD and mifepristone treatment as factors. Statistical significance of main effects is shown in the last three columns (ns = not significant).
| Vehicle | Mifepristone | |||
|---|---|---|---|---|
| No MD | MD | No MD | MD | |
| 0.20 ± 0.02 | 0.20 ± 0.01 | 0.20 ± 0.02 | 0.20 ± 0.01 | |
| 0.29 ± 0.01 | 0.29 ± 0.003 | 0.30 ± 0.01 | 0.29 ± 0.01 | |
| 0.26 ± 0.01 | 0.26 ± 0.004 | 0.27 ± 0.01 | 0.26 ± 0.01 | |
| 0.26 ± 0.01 | 0.26 ± 0.004 | 0.26 ± 0.01 | 0.26 ± 0.01 | |
| 0.25 ± 0.01 | 0.26 ± 0.01 | 0.26 ± 0.01 | 0.26 ± 0.01 | |
| 0.24 ± 0.01 | 0.25 ± 0.01 | 0.24 ± 0.01 | 0.25 ± 0.01 | |
| 0.24 ± 0.01 | 0.25 ± 0.01 | 0.24 ± 0.01 | 0.25 ± 0.01 | |
| 0.24 ± 0.01 | 0.25 ± 0.01 | 0.25 ± 0.01 | 0.25 ± 0.01 | |
| 0.52 ± 0.046 | 0.52 ± 0.012 | 0.52 ± 0.027 | 0.50 ± 0.045 | |
| 0.23 ± 0.004 | 0.24 ± 0.002 | 0.23 ± 0.002 | 0.23 ± 0.005 | |
| 0.23 ± 0.007 | 0.22 ± 0.004 | 0.22 ± 0.005 | 0.22 ± 0.008 | |
| 0.18 ± 0.004 | 0.18 ± 0.002 | 0.18 ± 0.004 | 0.18 ± 0.005 | |
| 0.20 ± 0.004 | 0.20 ± 0.003 | 0.19 ± 0.003 | 0.19 ± 0.005 | |
| 0.20 ± 0.004 | 0.20 ± 0.003 | 0.20 ± 0.002 | 0.20 ± 0.005 | |
| 0.20 ± 0.005 | 0.20 ± 0.004 | 0.19 ± 0.004 | 0.19 ± 0.004 | |
| 0.20 ± 0.004 | 0.20 ± 0.003 | 0.19 ± 0.004 | 0.19 ± 0.006 | |